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ABSTRACT 
BACKGROUND:  Complex abdominal aortic aneurysm (AAA) is a relatively common 
presentation to the vascular specialist. Despite this there is little consensus on how to manage 
the often co-morbid group of patients. Recent advances in endovascular technology have led 
to the availability of multiple devices, many of which could be used to treat the same 
aneurysm. The aim of this study was to quantify this potential variability across vascular 
specialists from multiple countries.  
 
METHODS: An online survey was emailed to members of the Vascular Society for Great 
Britain and Ireland (VSGBI), the Canadian Society for Vascular Surgery (CSVS) and the 
Australian and New Zealand Society for Vascular Surgery (ANZSVS). The survey presented 
a vignette of a 63-year-old woman with significant respiratory co-morbidity and a 54 mm 
juxtarenal AAA (7 mm neck). There were no other adverse morphological features for 
endovascular repair. The survey included images and questions related to management of the 
aneurysm. 
 
RESULTS: 238 responses were received; 61 from ANZSVS, 65 from CSVS and 112 from 
VSGBI. VSGBI specialists were significantly more likely to continue surveillance than both 
ANZSVS (odds ratio (OR) 3.41, 95% confidence interval (CI) 1.61-7.65; p<0.001) and 
CSVS counterparts (OR 2.61, 95% CI 1.29-5.47; p<0.01). ANZSVS specialists were 
significantly more likely to perform an endovascular repair than those from CSVS (OR 3.28, 
95% CI 1.50-7.40; p<0.01) and VSGBI (OR 3.65, 95% CI 1.81-7.59; p<0.001). CSVS 
specialists were significantly more likely to manage the aneurysm with open surgery than 
colleagues from the VSGBI (OR 6.57, 95% CI 2.58-18.46; p<0.001) and ANZSVS (OR 7.18, 
95% CI 2.22-30.79; p<0.001). 
 CONCLUSIONS: Significant variation in the management of a juxtarenal AAA between 
countries was observed. The same patient would be more likely to have an endovascular 
repair in Australia and New Zealand, open surgery in Canada and continuing surveillance in 
the UK and Ireland. This variation reflects the lack of long-term evidence and international 
consensus on the optimal management of complex AAA. 
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INTRODUCTION 
For abdominal aortic aneurysms (AAAs) with a favorable morphology, endovascular 
repair has become the predominant treatment.1,2 Open surgical repair remains an option for 
young or fit patients with adverse anatomic features precluding a standard endovascular 
aneurysm repair (EVAR),3 but these cases must be carefully selected. Treatment of complex 
aneurysms with endovascular procedures is a constantly evolving field, and techniques are 
being developed to circumvent anatomic constraints such as short or angulated necks. 
Fenestrated or branched EVAR extends the sealing zone of the graft proximally with custom 
made stents including windows for the renal and/or visceral arteries. Chimney, periscope or 
snorkel EVAR requires catheterization of at least one branch vessel in order to place a 
covered stent that runs parallel to the main body. This technique may also be combined with 
endovascular aneurysm sealing (EVAS). Standard EVAR devices can be secured with 
endoanchors in the proximal sealing zone whilst new generation models are being developed 
allowing their use in a wider range of anatomies. All have been proposed as treatment options 
for aneurysms with hostile neck anatomy 
There is little high level evidence comparing the efficacy of standard and complex 
endovascular, and open surgical procedures.4,5 It is perceived that specialists dealing with 
complex aneurysms may individualize the treatments they offer from patient to patient. This 
might depend on the experience of the vascular specialist, the expertise of their centre and the 
preferences of the patient. Our objective was to assess current practice and explore potential 
variability in the management of complex AAA by conducting a survey among vascular 
specialists. 
 
 
    
METHODS 
A 10-part online questionnaire was composed using the Bristol Online Surveys tool, 
which is designed for academic research, educational and public sector organizations.6 An 
email invitation to complete the questionnaire was sent to all listed members of the Vascular 
Society for Great Britain and Ireland (VSGBI), the Canadian Society for Vascular Surgery 
(CSVS) and the Australia and New Zealand Society for Vascular Surgery (ANZSVS). This 
comprised 650 VSGBI members, 196 ANZSVS members and 155 CSVS members. A 
reminder email was sent two weeks later and the survey was open for five months from 5th 
September 2016 to 8th February 2017. The societies were not involved in the design of the 
study.  
 The questionnaire described a brief clinical scenario based on the real-life case of a 
63-year old woman referred to the Department of Vascular and Endovascular Surgery in the 
Pennine Acute Hospitals NHS Trust (Manchester, UK) for management of a 54 mm AAA 
with a short (7mm) infra-renal neck (Appendix I). There were no other radiological contra-
indications to standard or complex EVAR. No patient identifiable data was revealed. The 
clinical description was accompanied by a sagittal and coronal view of the computed 
tomographic (CT) angiogram presenting the para-renal/visceral segment of the aorta (Figure 
1). The patient was unable to complete a cardiopulmonary exercise test due to severe chronic 
obstructive pulmonary disease and hip osteoarthritis. The questionnaire presented treatment 
options based on the clinical scenario and CT imaging, including conservative management. 
It also contained questions relating to the operating facilities in the employing hospital 
(whether surgeons operate in a hybrid theatre, a standard operating room or a radiology 
angiosuite), country of medical practice, and stage in training of the participants (whether  
trainee or specialist).  
 Data were processed and analysed using the R Statistical Package version 3.3.1.7 
Fisher’s exact test was used to perform univariate analysis for categorical variables, and 
effect sizes quantified using odds ratios with 95% confidence intervals. Multivariate logistic 
regression was used to assess the effect of access to a hybrid operating theatre, adjusting for 
the effect of country. A p-value of less than 0.05 was considered statistically significant. This 
study was assessed to be an evaluation of service and thus required no formal ethical 
approval. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
In total, there were 238 responses from 1001 members contacted (23.8%). 61 were 
received from the 196 ANZSVS members (31%,), 65 from the 155 CSVS members (42%) 
and 112 from the 650 VSGBI members (17%). The response rates from the three societies 
were significantly different (p<0.001). Of the 234 responders who stated a grade, 96% were 
consultant specialists. 52% of responders had access to a hybrid theatre whereas the 
remaining 48% did not. There was no significant difference in provision of hybrid theatres 
between ANZSVS (54%), CSVS (55%) and VSGBI (49%). 
Endovascular repair was the most commonly chosen first line management strategy 
(46%) followed by ongoing surveillance (35%) then open surgical repair (14%). The 
breakdown between individual countries was varied, as outlined in Figure 2. In Great Britain 
and Ireland, ongoing surveillance was most prevalent (48%) followed by endovascular repair 
(38%). In Australia and New Zealand, 69% of responders chose an endovascular first strategy 
followed by 21% recommending ongoing surveillance. The majority of Canadian responders 
also advocated endovascular treatment (40%) with open repair being the next most common 
solution (34%).  
In total, 35% of vascular specialists chose ongoing surveillance whilst 61% chose to 
intervene. The remaining 4% did not think intervention or surveillance was appropriate; this 
comprised 8 responders from VSGBI (7%) and 2 from ANZSVS (3%). Specialists in Great 
Britain and Ireland were more likely to adopt surveillance than their colleagues in Australia 
and New Zealand (odds ratio (OR) 3.41, 95% confidence interval (CI) 1.61-7.65; p<0.001) 
and Canada (OR 2.61, 95% CI 1.29-5.47; p=0.0043). Australian and New Zealand specialists 
were significantly more likely to offer endovascular repair than specialists in Canada (OR 
3.28, 95% CI 1.50-7.40; p=0.0014) and Great Britain and Ireland (OR 3.65, 95% CI 1.81-
7.59; p<0.001). Canadian specialists were significantly more likely to manage the aneurysm 
with open surgery than colleagues in Great Britain and Ireland (OR 6.57, 95% CI 2.58-18.46; 
p<0.001) or Australia and New Zealand (OR 7.18, 95% CI 2.22-30.79; p<0.001). Access to a 
hybrid operating theatre did not significantly affect the initial treatment strategy (Table 1). 
Of those choosing ongoing surveillance the median size at which to then intervene 
was 60 mm in all countries. The spread of treatment thresholds is shown in Figure 3. Choice 
of intervention at any threshold is outlined in Figure 4. Endovascular management was 
preferred by 80% of responders and open repair by the remaining 20%. When split into 
countries, 92% of interventions in Australia and New Zealand were endovascular compared 
to 83% in Great Britain and Ireland and 61% in Canada (Figure 5). The most common 
method of endovascular repair was FEVAR (84%) followed by EVAR with endoanchors 
(6%). The remaining 10% were a mixture of standard or chimney EVAR or EVAS (Figure 
6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSIONS 
An unfit patient with an AAA unsuitable for standard EVAR approaching threshold 
for treatment is a common presentation globally. We aimed to investigate potential variability 
in treatments offered to a typical patient such as this, assess whether treatments differ across 
vascular specialists from different parts of the world, and characterize any potential 
differences using a survey. Vascular Societies from Canada, Australia and New Zealand, and 
Great Britain and Ireland were chosen to give a view of current vascular surgical practice 
across different countries.   
 There was heterogeneity in the management of the complex AAA case presented. 
Most surgeons surveyed would manage the patient operatively, with 61% choosing to 
intervene immediately. Endovascular repair was the most common first line management 
strategy for those who chose to intervene.  
There were interesting differences in the management of the patient between 
countries. VSGBI specialists were significantly more likely to continue surveillance than both 
ANZSVS and CSVS. Canadian specialists were significantly more likely to perform open 
surgery than surgeons from Great Britain and Ireland or Australia and New Zealand, and 
ANZSVS were significantly more likely to treat the aneurysm with endovascular repair than 
VSGBI and CSVS. The same patient would therefore potentially be treated differently 
depending on which country they presented in. The operating environment which the 
surgeons had access to did not significantly vary between countries, and multivariate 
adjustment for this factor did not significantly affect initial treatment strategy (Table 1).  
In all countries surveyed, endovascular management was the most popular choice of 
intervention once treatment threshold had been reached. Modern vascular training is changing 
to embrace the endovascular revolution with incorporation of interventional radiology 
modules and assessments. It is however important to ensure that expertise in open surgical 
treatment of AAAs is maintained given the subset of patients for which this is likely to be the 
most durable and effective treatment. The endovascular alternatives outlined above have 
vastly increased the proportion of aneurysms which can be treated without open surgery, but 
long term data on their efficacy is lacking at present. Recent publication of the 15 year 
EVAR-1 results8 has cast doubt on the durability of endovascular repair with increased total 
and aneurysm-related mortality in the EVAR arm from 8 years onwards, as well as re-
intervention rate from 6 months onwards. If these findings were to be replicated in patients 
treated with complex EVAR it may lead to a paradigm shift in the treatment of AAA. 
Surgeons in countries heavily reliant on endovascular therapy are at risk of losing the skills 
developed over decades of open surgical practice, and the ability to pass these on to their 
trainees. This would potentially lead to difficulties providing a balanced and comprehensive 
set of aneurysm treatment options for all patients. 
 For those that chose to continue surveillance of the aneurysm prior to treatment, the 
treatment threshold demonstrated some variability with 23% choosing <60 mm, 70% 
choosing 60 mm and 7% choosing >60 mm. Despite the median threshold of 60 mm being 
the same in each of the 3 countries surveyed, the range of figures represent the difference in 
opinion between individual clinicians when making treatment decisions. This reflects 
variability in clinical practice throughout the world.9 
Another influence on the specialist’s decision making process that we must consider 
is the cost of the procedure. It has been established that patterns of reimbursement change the 
proportion of standard EVAR and the treatment threshold in different countries,10 but this has 
not been assessed for management of complex AAA. Standard EVAR has been reported to be 
less cost-effective in elective cases,11 but in systematic reviews of juxta-renal aneurysm 
management there is insufficient comparative data to draw any cost-effectiveness 
conclusions.12  
A survey-based method is in itself a limitation of this study. The response rate was 
significantly lower from the UK and Ireland (17%), with Canada having the highest rate at 
42%, followed by Australia and New Zealand at 31%. Given the differences in response 
rates, particularly from practitioners in the UK and Ireland, the findings cannot be held as 
wholly representative. Further questions, including discovering the reasons for chosen 
management plans and volume of work in centers were considered, but the survey was kept 
brief and anonymous in an attempt to increase the response rate and reduce the likelihood of 
‘survey fatigue’. 
 Other limitations included the inability of the online survey method to give a full 3D 
representation of the scans and a full consultation with the patient. Responding to the survey 
itself was optional, so our responders may have self-selected into a group which were 
particularly interested in the management of complex aneurysms.  
 In conclusion, our main finding in the results of this survey was the heterogeneity in 
management of a complex AAA among specialists worldwide. This could be explained by 
the lack of high level evidence demonstrating benefits of one therapeutic method over 
another.4 The introduction of novel endovascular techniques such as EVAS, FEVAR and 
chimney grafts has been relatively recent, and long-term data on outcomes are awaited. In 
order to make the best and safest decisions with our patients, it is important that future 
research is carried out to inform us of the precise risks and benefits of each treatment method. 
This will be aided by the National Vascular Registry in the UK and Ireland, and counterparts 
from other countries. We believe that continuous monitoring of our practices and outcomes, 
both within individual units and internationally through audit and validated registries, and the 
communication of good practice is vital to broaden the evidence base for complex aneurysm 
repair.  
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